Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.
Lisandro D ColantonioKeri L MondaRobert S RosensonTodd M BrownKatherine E MuesGeorge HowardMonika M SaffordLarisa YedigarovaMichael E FarkouhPaul MuntnerPublished in: Cardiovascular drugs and therapy (2020)
The CVD event rate is high among African Americans and whites meeting the FOURIER inclusion criteria. Characteristics associated with a higher CVD risk may inform the decision to initiate PCSK9 inhibition.